LIM kinase inhibitors
A kinase, C1-C6 technology, applied in the field of LIM kinase inhibitors, can solve the problem of no small molecule Limk inhibitors reported in the literature
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0121] illustrate
[0122] Our group reported a novel pyrazole-phenylurea skeleton 1( figure 1 ) as a potent and selective Rho kinase (ROCK) inhibitor that has a reducing effect on severe intraocular pressure (IOP) in rat eyes. 41,42 Compound 1 has low Limk inhibition (IC50>10 μM) in count-screen studies. However, SAR studies showed that substitution of the hinge-binding moiety pyrazole in 1 with 4-yl-pyrrolopyrimidine (compound 2) significantly reduced its ROCK-II affinity (ROCK-III C50 = 188 nM of 2 vs. 2 nM of 1)). Compound 2, on the other hand, achieved modest Limk1 inhibition (Limk1 IC50 = 642 nM vs. 10 μM of 1), revealing an interesting hinge-binder-dependent kinase selectivity of this phenylurea-based scaffold. Further modification of compound 2 at its urea terminal side resulted in compound 3 ( figure 1), which has an even weaker ROCK-II affinity (IC 50 =1365 nM) but improves Limk1 biochemical capacity (IC 50 =201 nM). Interestingly, the 4-yl-pyrrolopyrimidine mo...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com